Scopolamine Patch, Extended Release
Product Images NDC 50090-8154

8 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Scopolamine (NDC 50090-8154). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 01)

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 01)
Chemical structure diagram of Scopolamine showing its molecular arrangement including a bicyclic ring system with nitrogen, oxygen, and methyl groups, as well as a phenyl and carboxyl group.*
FDA Label Image

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 02)

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 02)
An instructional diagram illustrating layers of a Scopolamine transdermal patch, extended release. The diagram labels the patch's components from top to bottom: Backing Membrane, Drug Layer, Rate Controlling Membrane, Contact Layer, and Release Liner.*
FDA Label Image

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 03)

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 03)
An instructional illustration showing a Scopolamine transdermal patch with labeled parts including a clear disposable release liner, adhesive surface, and tan backing membrane printed with "Scopolamine 1 mg/3 days." The image aids understanding of patch components for application.*
FDA Label Image

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 04)

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 04)
An instructional diagram showing a tear package with a notch and slit, illustrating how to open it along these features. The image guides the user on proper opening of the package.*
FDA Label Image

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 05)

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 05)
An instructional illustration showing two hands peeling apart the backing of a transdermal patch, likely demonstrating how to open and apply the Scopolamine patch. The image is labeled as Figure 3.*
FDA Label Image

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 06)

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 06)
An instructional diagram showing a hand holding a Scopolamine transdermal patch with labeled parts: imprinted tan-colored transdermal system, adhesive surface, and clear disposable release liner. The image illustrates how to hold and prepare the patch for application.*
FDA Label Image

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 07)

Image (A673f990 Bfdf 4d84 B63f C1b2ba4c9e36 07)
Illustration showing a side profile of a human head with a transdermal patch applied behind the ear. The patch is labeled as an imprinted, tan-colored extended release transdermal system for Scopolamine.*
FDA Label Image

Label Image (Lbl500908154)

Label Image (Lbl500908154)
Scopolamine 1 mg/3 days transdermal patch label from A-S Medication Solutions. The label states each patch contains 1.23 mg of scopolamine in a film system for release over 3 days. Storage instructions specify 68 to 77 degrees Fahrenheit. The label includes product number 6966-0, NDC 50090-8154-0, and distributor information for A-S Medication Solutions, Libertyville, IL 60048.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.